Cases and resources in vascular techniques
This section provides a selection of cases and resources provided by experts in vascular techniques.
This PVI 2025 symposium explores the role of IVUS in peripheral arterial disease, from understanding vessel biology and mechanisms of failure to reviewing the growing evidence supporting IVUS use, particularly in CLTI. Through expert insights and real-life, IVUS-guided cases, the session shows how imaging can directly inform vessel preparation and treatment decisions in daily practice.
This PVI 2025 session showcases how vascular care is delivered across the Asia-Pacific region. It covers research regulations in New Zealand, DVT management in Singapore, CFA treatment in Japan, acute lower limb ischemia in Malaysia, pulmonary embolism repair in India, real-world Ranger DCB outcomes in CLTI patients, and aortic dissection management in China.
Dr. Prakash Krishnan breaks down bioresorbable scaffolds after the LIFE-BTK trial. Discover how these drug-eluting scaffolds may help in dissections and recoil, offering temporary support without compromising future treatments. Challenges remain—long lesions, above-the-ankle use, and vessel prep are still under investigation. Watch now to see what this means for complex CLTI care!
By watching this session, you will learn the following: describe at least 4 different strategies to manage endovascularly arterial bifurcations, determine what is the best endovascular option to manage lesions of the aorto-iliac, iliac, femoral or below-the-knee arterial bifurcations, and associate strategies from cardiology and interventional surgery to offer the most appropriate endovascular treatment for each arterial bifurcation lesion.
This session explores today’s key questions in venous practice: is foam still justified in 2025? How do non-thermal techniques compare? And in combined superficial and deep disease, what should be treated first? With focused discussions on severe ulceration and deep venous insufficiency, it offers clear, practice-oriented insights to guide real-life decision-making.
By watching this session, you will learn the following: implement a multidisciplinary strategy involving vascular surgeons for TAVI and pediatric vascular strategy, create a personalized open vascularization plan for failed EVAR, and better select patients that require treatment of type II endoleaks.
This PVI 2025 session reviews AAA management, from reconsidering treatment thresholds and improving patient selection to predicting EVAR failure and optimising radiation protection. It highlights the importance of risk-based decision-making, sealing zone assessment after EVAR as a predictor of outcomes, and practical strategies to reduce radiation exposure in the hybrid OR.
